Monthly Archives: May 2015

RealtyPact Launches, Providing Professional, Signature-Ready Real Estate Paperwork

Company’s accessible paperwork accounts for unique details of every transaction while costing only a fraction of what attorneys charge, RealtyPact reports

Cleveland, OH, United States of America – May 27, 2015 /MarketersMedia/ —

The founders of RealtyPact announced that the new real estate document preparation service has launched and is now available to clients. The new service takes a unique, much-needed stand on the formerly barren middle ground between difficult do-it-yourself real estate contracts, on the one hand, and expensive attorney hours or realtors and their commissions, on the other. RealtyPact is the easiest and most cost-effective way to conduct for-sale-by-owner transactions, quitclaim deeds, and other real estate transfers. Working with RealtyPact is simple, reliable, and straightforward compared with generalized, do-it-yourself contracts, but can save clients thousands off the fees attorneys or agents normally charge.

“We’re thrilled to announce that our new service is now online and doing business,” RealtyPact Director of Marketing and Operations Allen Freeman said, “There is no longer any reason at all to struggle with finishing normal off-the-shelf real estate paperwork. Our affordable real estate paperwork ready for signature handles the specific details of every transaction, while saving our clients thousands of dollars.”

Becoming more common for decades, for-sale-by-owner home sales now account for nearly 10% of all such deals in the United States, according to a 2014 National Association of REALTORS report. That same source identified the greatest hurdle for owners who go this route as being the understanding and preparation of paperwork, with a full 50% more sellers labeling this the top difficulty than did the next most common problem.

In the past, owners who manage the sales of their own homes have had two basic options: Either spend thousands of dollars on attorney fees, or try to make use of generic, off-the-shelf real estate contract forms or software. Neither path has proven to be satisfying in general, a longstanding issue that RealtyPact was founded to address.

At incredibly affordable prices, the new service provides any necessary real estate documents, all customized and completed to the point that they are ready for signatures. Within three business days after contacting the company and paying a fee that is competitive with that charged for generic offerings, RealtyPact clients can have all of the necessary paperwork in hand and ready to go, along with simple filing and usage instructions, as well.

The new company even provides simple phone-based and mail-in questionnaire options for those who would rather not supply the necessary information by computer. Any person who would like to conduct a real estate transaction without paying expensive agents or attorneys, then, can now do so with RealtyPact, while enjoying the low prices normally associated with confusing, incomplete do-it-yourself forms. With for-sale-by-owner deals only becoming more popular, RealtyPact arrives at exactly the right moment to save countless people money and save them from making potentially costly mistakes.

About RealtyPact:
RealtyPact supplies sellers and others with highly affordable, professionally prepared real estate paperwork that is ready to receive signatures, saving clients money and doing away with the confusion and dangers of the common do-it-yourself options.

For more information about us, please visit https://www.realtypact.com

Contact Info:
Name: Allen Freeman
Organization: RealtyPact
Phone: 1-800-624-8175

Source: http://marketersmedia.com/realtypact-launches-providing-professional-signature-ready-real-estate-paperwork/82947

Release ID: 82947

Lexaria Looks to Validate Breakthrough Technology

WHITEFISH, MT / ACCESSWIRE / May 27, 2015 / The medical cannabis industry has
grown at a 16.2% compound annual growth rate between 2009 and 2014 to reach $2
billion in revenue, according to IBISWorld,
driven by state legalization initiatives and research conducted by companies
like GW Pharmaceutical plc (NASDAQ: GWPH). GreenWave
Advisors believes that figure could reach $35 billion by 2020 if all 50
states legalized the drug and the federal government ended prohibition.

Lexaria Corp. (OTCQB:
LXRP) (CSE: LXX), a food sciences company focused on the delivery of
cannabinoid compounds using its proprietary infusion technology, plans to
capitalize on the rapidly growing industry by improving the bioavailability of medical
cannabis. In addition, it was only weeks ago that Lexaria appointed a new company
president, Mr John Docherty, who has an extensive and accomplished background
from the pharmaceutical industry. Lexaria seems to be taking bona fide steps to
position itself as a leading technology force within the industry.

Importance of Bioavailability

Many cannabis users know that
smokable and edible forms of the drug produce completely different experiences.
In a 2005 study,
researchers found that smoking cannabis resulted in 30% bioavailability of THC,
while oral consumption resulted in just 4% to 12% bioavailability. A separate 2012 study found that the
bioavailability of CBD was around 31% when smoked and just 6% when taken
orally.

Researchers believe that the difference between
smoked and oral consumption of the drug stem from the so-called first-pass
effect – a phenomenon of drug metabolism whereby the concentration of a drug is
greatly reduced before it reaches systemic circulation. Often times, the
fraction of the drug lost during the absorption process occurs in the liver and
gut wall where the drug is metabolized before reaching the rest of the body.

Lexaria’s patent-pending process
actively binds CBD ingredients with a lipid in order to enable a more efficient
delivery and absorption of CBDs and other cannabinoids when consumed orally
versus being smoked. In May, the company announced that Absorption Systems LP
would begin third-party in vitro
tests using a human intestinal tissue model to evaluate the CBD permeability of
its technology that infuses cannabinoid compounds within lipids.

Significant Potential

Lexaria’s technology could disrupt
the entire legal cannabis market if these lab tests show that its technology
delivers a bioavailability rate near that of smoking. As CEO Chris Bunka said
in a recent
interview with CannabisFN on the topic, “Why would any medical marijuana
patient contemplate smoking ever again if we can actually deliver as much
active ingredient with no harmful effects, as associated with smoking?”

Medical marijuana patients that need
the higher bioavailability of smoking marijuana to alleviate their pain
symptoms could use the technology to avoid smoking, while the general public
could benefit from wider bioavailability of CBD. The company’s existing product
line – including ViPova teas – address this mass market with a product that’s
easily consumed, while management plans to launch additional food and beverage
products to consumers over the coming quarters.

And while Lexaria’s current focus
is clearly on developing food based delivery mechanisms for CBD-fortified
products, Bunka reminded CannabisFN that the patent applications have been
filed for both CBD and for THC. If the third-party in vitro lab test results are strongly positive, the potential for
this technology to be disruptive across the industry is apparent.

Earlier this year, the company
hired a National Sales and Compliance Strategist to spearhead its U.S.
sales operations and launched its initial Tea Party campaign to encourage
grassroots growth. A channel
partner program was also established to help facilitate the build-out of
distribution channels throughout the country by working with exclusive retail
operations or distributors across a number of different markets and verticals.

Near-term Catalysts

Lexaria expects to begin testing of
its technology in the near future and will report results when they are
available within the next three or four months. If successful, the testing
could provide a significant catalyst for the stock given the potential within
the cannabis market.

It is significant to note the time
period in which their trials will be conducted, unlike a company that is taking
a path to commercialization via FDA clinical trials (which can and do take many
years to complete), Lexaria has chosen to go down a path where testing results
will be turned around in a matter of months.

If proven effective, there should
also be significant interest in the technology on the part of third party
manufacturers, as the amount of THC and CBD’s that are needed to produce the
same effect in edibles will be diminished.

Investors in the nutrition and
supplements industry, including Forever Green Worldwide Corp. (OTCQB: FVRG) and Youngevity International Inc. (OTCQX: YGYI), may want to take a closer look at the
stock given their similarities in market capitalization. In addition, investors
in cannabis research companies, like Cannabis Sciences Inc. (OTC Pink: CBIS) and Cannabics Pharmaceuticals Inc. (OTC Pink: CNBX), may also be interested in learning
more.

For more information, visit the
company’s website at www.lexariaenergy.com
or visit CannabisFN’s Lexaria
Corp. Profile to see exclusive interviews and content.

Legal Disclaimer:

Except for the historical information presented herein, matters
discussed in this article contain forward-looking statements that are
subject to certain risks and uncertainties that could cause actual
results to differ materially from any future results, performance or
achievements expressed or implied by such statements. Emerging Growth
LLC dba TDM Financial, which owns CannabisFN, is not registered with any
financial or securities regulatory authority, and does not provide nor
claims to provide investment advice or recommendations to readers of
this release. Emerging Growth LLC dba TDM Financial, which owns
CannabisFN, may from time to time have a position in the securities
mentioned herein and may increase or decrease such positions without
notice. For making specific investment decisions, readers should seek
their own advice. Emerging Growth LLC dba TDM Financial, which owns
CannabisFN, may be compensated for its services in the form of
cash-based compensation or equity securities in the companies it writes
about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

SOURCE: Cannabis Financial Network

ReleaseID: 429274

Sterilization Technologies Market Trends, Company Share To 2019: Hexa Research

HexaResearch.com has announced the addition of “Global Sterilization Technologies Market Analysis And Segment Forecasts, 2013 – 2019” Market Research report to their Database.

Sterilization makes sure harmless products for human consumption and commercial processes. Recent regional market development has created the need for effective, swift and cost-effective technologies that ensure safety all through the production process. This report analyzes the key processes of filter, chemical, heat and radiation sterilization. Market trends are analyzed and global market estimates for the manufacturing, pharmaceutical, food & beverage equipment and consumables are provided.

Full research report on Global Sterilization Technologies Market with detailed figures and charts available at:
http://www.hexaresearch.com/research-report/sterilization-technologies-industry/

The global market of sterilization capital equipment and filtration consumables was worth USD 3.34 billion in 2010 and USD 3.85 billion in 2011. This market is expected to grow at a CAGR of 7.2% from 2013 to 2019.

The filter sterilization market segment including equipment and consumables was estimate at USD 2.11 billion in 2011 and is expected to grow at a CAGR of 9.5% from 2013 to 2019. The liquid filtration segment reached USD 1.11 billion in 2010 and USD 1.42 billion in 2011. It is expected to grow at a CAGR of 11.0%. Capital equipment sales for heat sterilization technologies was worth USD 1.10 billion in 2011 and is expected to grow at a CAGR of 3.6% from 2013 to 2019.

Get more information on Global Sterilization Technologies Market research report at:
http://www.hexaresearch.com/research-report/sterilization-technologies-industry/

This research report provides comprehensive market statistics and forecast for key segments, and provides complete industry landscape including drivers, restraints, regulatory scenario, technology trends and future opportunities. The report also provides detailed competitive landscape with company market share analysis and in-depth profiles of key market participants. Key regional markets analyzed and reported in this study include:

North America
Europe
Asia Pacific
RoW

Critical elements of the report include:

Industry dynamics
Market challenges and opportunities
Technology & regulatory trends
Market estimate and forecast
Regional trends
Competitive trends

Why should you buy this report?

This report provides comprehensive analysis of the market including Porter’s and SWOT analysis
Complete identification and analysis of key industry dynamics including drivers, restraints, raw material trends and buyer behavior
The study provides technology landscape and regulatory trends for building strategy
Global and regional market estimates and forecast on volume and revenue basis for multiple market segments
Detailed competitive landscape of the market, with profiles of key companies

To request or view other reports of this category, click the link below:
http://www.hexaresearch.com/research-category/healthcare-industry/

About Hexa Research

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, visit: http://www.hexaresearch.com/

This research report can also be accessed at:
https://www.linkedin.com/pulse/sterilization-technologies-market-trends-company-share-komal-deshmukh

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/05/1432703813.jpeg

“HEXA RESEARCH”

Media Contact
Company Name: Hexa Research
Contact Person: Michelle Thoras
Email: sales@hexaresearch.com
Phone: +1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.hexaresearch.com/research-report/sterilization-technologies-industry/

Source: ABNewswire

ReleaseID: 29050

Makemoneywithdropshipping.com Celebrates Its 15388 Sale

May 27, 2015 – – Spokane, Washington – May, 29 2015 – Dropshipping Innovation, a unique, online based, merchant supply chain agency is celebrating its15388 sale after a 4 year run.

Online Drop Shipping is a merchant supply chain methodology where online stores are able to sell products that they do not have in stock. What happens is online stores list a product and when a buyers commits and buys it, the stores make an order to the real seller—most often a wholesaler or manufacturer. The real seller then has to directly deliver the items or service to the buyer. It is a form of brokering, so the initial seller simply makes a commission or a profit out of the sale and lets the real seller deal with product sourcing, shipping, delivery and customer support.

One of the reasons that Drop Shipping is picking up, especially as a work at home business, is because it requires very little capital on the part of the initial seller. To make a sale, the initial seller simply needs to list the item or show its image and convinces the buyer to buy. This also eliminates the need to stock, warehouse or ship the product. That is why any business or individual can do it; regardless of its location or products it wants to sell.

But, like any new technology, online Drop Shipping was confusing, laced with challenges and suffered slow adoption at first. During the first two years, Dropshipping Innovation had only 100 sellers. But it has slowly picked up and currently has 866 sellers. This is the reason the company is marking this milestone by celebrating its 15388 sale. Much of this success is attributed to, managing the business risks, effective marketing and getting positive customer testimonies. For example, one of the sellers by the name of George, has this to say, “I am making steady money now and now I can afford something that I have long wanted to buy.”

Dropshipping Innovation recently launched its new website at MakeMoneywithdropshipping.com. This is an American company co-owned and manged by Rachel Ewine. It started its operations in 2011 and currently has 866 affiliated sellers that are selling products through its program. The company is open to anyone that has an Ebay or Amazon account and aims to triple its current sales by August this year.

###

Contact Master Media:

Rachel Ewine
410 633 0178
ewinerachel@gmail.com
439 Folcroft St
Baltimore MD 21224-2802
United States

ReleaseID: 60001379

Global Optical Coherence Tomography (OCT) Market Analysis, Size, Share, Growth To 2019 by Hexa Research

HexaResearch.com has announced the addition of “Global Optical Coherence Tomography (OCT) Market Analysis And Segment Forecasts, 2013- 2019” Market Research report to their Database.

“HEXA RESEARCH”

Research and development in the field of Optical Coherence Tomography has revealed its current usage in various applications and shows foreseeable usage in the near future. The report also discusses the usage of Optical Coherence Tomography techniques over other imaging techniques such as magnetic resonance imaging and ultrasound imaging. Researchers and market players are exploring the advantages of Optical Coherence Tomography in newer areas, leading to the increased applications and consumption of these techniques. Research and development spending, patents and research in this field are giving a new direction. Technological advancements, early disease detection and awareness among people influenced the market to grow in the foreseeable future.

Full research report on Global Optical Coherence Tomography (OCT) Market with detailed figures and charts available at:
http://www.hexaresearch.com/research-report/optical-coherence-tomography-industry/

The global market for optical coherence tomography (OCT) was estimated at USD 582.8 million in 2011, which reached USD 647.4 million in 2012. The optical coherence tomography market is further expected to grow at a CAGR of 9.8% from 2013 to 2019.

North America
Europe
Asia Pacific
RoW

Get more information on Global Optical Coherence Tomography (OCT) Market research report at:
http://www.hexaresearch.com/research-report/optical-coherence-tomography-industry/

Critical elements of the report include:

Industry dynamics
Market challenges and opportunities
Technology & regulatory trends
Market estimate and forecast
Regional trends
Competitive trends

Why should you buy this report?

This report provides comprehensive analysis of the market including Porter’s and SWOT analysis
Complete identification and analysis of key industry dynamics including drivers, restraints, raw material trends and buyer behavior
The study provides technology landscape and regulatory trends for building strategy
Global and regional market estimates and forecast on volume and revenue basis for multiple market segments
Detailed competitive landscape of the market, with profiles of key companies

To request or view other reports of this category, click the link below:
http://www.hexaresearch.com/research-category/healthcare-industry/

About Hexa Research

For more information, visit: http://www.hexaresearch.com/

This research report can also be accessed at:
https://www.linkedin.com/pulse/optical-coherence-tomography-market-analysis-share-growth-deshmukh

Source: ABNewswire

ReleaseID: 29049

Neurostimulation Devices Market Growth, Size, Industry Trends To 2020 by Hexa Research

HexaResearch.com has announced the addition of “Global Neurostimulation Devices Market Analysis And Segment Forecasts, 2012 – 2020” Market Research report to their Database.

“HEXA RESEARCH”

Growing geriatric population base and rising incidences of target diseases such as Alzheimer’s and Parkinson’s are the major drivers for this market. As per an estimate by the Alzheimer Disease International 36 million people globally had Alzheimer’s or a related dementia. Limited treatment options for diseases such as migraine and epilepsy has led to high unmet medical needs of patients in this segment, and thus is a high impact rendering driver for the neurostimulation devices market. Spurred use of neuromodulation devices as an add-on therapy, growing demand for minimally invasive surgery and the technological advancements such as Neurowave Medical Technologies transdermal neuromodulation technology and MRI safety enabled neurostimulator by Medtronic, are expected to further augment the growth of the neurostimulation devices. Untapped, rapidly growing markets of Asia and Latin America have presences of abundant unmet needs and thus offer future growth opportunities to the neurostimulation devices market. Manufacturing neurostimulation devices is an expensive manufacturing process the manufacturers thus, are adhering to outsourcing as an attempt to reduce the costs and maximize the overall profit margin. The key manufacturers are Boston Scientific Corporation, Cyberonics, Medtronic Inc. and St. Jude Medical.

Full research report on Global Neurostimulation Devices Market with detailed figures and charts available at:
http://www.hexaresearch.com/research-report/neurostimulation-devices-industry/

The products analyzed in the neurostimulation devices market include gastric electric stimulation device, deep brain stimulation device, vagus nerve stimulation device, spinal cord stimulation device and sacral nerve stimulation device. Spinal cord stimulation devices dominated the neurostimulation devices market in 2012 with over 60.0% revenue share. These devices hold a competitive edge over the other devices as they were the first to be commercialized, and thus have higher penetration rates. High prevalence of chronic pain, cost effectiveness in terms of quality adjusted life years are the major drivers for this segment. Deep brain stimulation devices held the second largest revenue share; these devices are currently going through experimental phase as they are based on nascent technology. These devices are FDA approved for the treatment of dystonia, Parkinson’s, and are awaiting approvals for treatment of obsessive compulsive disorder, refractory epilepsy, and cluster headache. Sacral stimulation devices are expected to grow at the fastest CAGR over the next six years owing to high prevalence of fecal and urinary incontinence.

Get more information on Global Neurostimulation Devices Market research report at:
http://www.hexaresearch.com/research-report/neurostimulation-devices-industry/

Key applications of neurostimulation devices are epilepsy, pain management, fecal and urinary incontinence, dystonia, Parkinson’s disease, gastroparesis, and essential tremor. Pain management, throughout the forecast period, is the largest application segment of neurostimulation devices market, owing to the high prevalence of chronic pain disorders globally. Growing adoption rate of neurostimulation devices in the field of pain management as a consequence of the high therapeutic value is also a major driver for this market. The neurostimulation devices for Parkinson’s disease are expected to grow at a rapid rate over the next six years on account of low availability of treatment options and growing global geriatric population base.

North America dominated the overall neurostimulation devices market during the forecast period. High patient awareness levels, high healthcare expenditure, sophisticated healthcare infrastructure in developed countries such as U.S., led to high growth of this market. Presences of industry friendly organizations such as American Tinnitus Association and North American Neuromodulation Society will boost the market positively. North America was followed by Europe in revenue share in 2012. Faster and relatively easy device approval process by CE, and the presences of large geriatric population base and fast economic development in Western and Eastern European countries, are the major factors contributing towards the growth of the market. Asia Pacific’s market is expected to grow at the fastest CAGR over the forecast period owing to presences of unmet medical needs, rising patient awareness levels and the gradually improving healthcare infrastructure in China and India.

Key companies analyzed for the research:

Medtronic Inc.
Codman and Shurtleff Inc.
Cervel Neurotech, Inc.
Cyberonics Inc.
Integra Life Sciences
St. Jude Medical
Nevro Corporation
Boston Scientific Corporation
Uroplasty Inc.
Neuronetics, Inc.
IntraPace Inc.

To request or view other reports of this category, click the link below:
http://www.hexaresearch.com/research-category/healthcare-industry/

About Hexa Research

For more information, visit: http://www.hexaresearch.com/

This research report can also be accessed at:
https://www.linkedin.com/pulse/neurostimulation-devices-market-growth-size-industry-trends-deshmukh

Source: ABNewswire

ReleaseID: 29048

Intertainment Media’s TranzActive Scores Knockout with Wearables Computer Start-Up Precision Fight Gear

TORONTO, ONTARIO &
NEW YORK, NEW YORK / ACCESSWIRE / May 27, 2015 / Intertainment Media Inc. (OTCPINK: ITMTF) (TSXV: INT) (I4T.F) (“Intertainment” or “Company”) is pleased to announce that TranzActive (www.tranzactive.com) the new marketing brand for Intertainment’s Ortsbo division, specializing in the management & development and technology assets as well as assisting start-ups and emerging growth companies, has signed an initial agreement with 2306619 Ontario Inc. operating as Precision Fight Gear (“PFG”), an organization that has developed a patented accelerometer technology to measure and display telemetry in the Boxing and Fitness industry. PFG owns US Patent 5723786, issued March 3, 1998, which explicitly covers the measurement of impact through the use of boxing gloves and reporting of data through a wireless system. PFG has developed key wearable computer technology around the patent that will connect to computers, tablets, mobile phones and smart watches.

Under the agreement, TranzActive will represent PFG for all its capital market programs and liquidity events as well as manage PFG’s intellectual property and all marketing and partnership programs. TranzActive will receive fees and equity participation as part of the business arrangement.

The impact of this technology on the fitness industry as well as the amateur and professional fight industry is potentially immense as users flock to add computerized bio feedback to their everyday lives.

“This is among our first agreements under the TranzActive banner to assist start-ups and emerging growth companies in the Internet technologies and clean-tech industries,” said Mr. Anthony R. Pearlman, President & COO of Intertainment Media Inc. “PFG is an exciting opportunity in the sports and fitness wearable computing industry supported by intellectual property, making it a perfect fit for TranzActive.”

According to Business Insider (http://www.businessinsider.com/wearable-computing-market-statistics-2015-1), BI reports that the wearables market is estimated to grow at a compound annual rate of 35% over the next 5 years and that is it estimated that by 2019, 148 million units will be shipped per year in comparison with an estimated 33 million units this year. Further, Broadcom reports (http://www.broadcom.com/blog/ces/whats-the-market-size-for-wearables-bigger-than-you-think-says-ces-expert/) that from 2013 to 2014, the wearables fitness market increased an estimated 35% with a worth of approximately $1 billion in 2014.

For more information, please visit http://www.tranzactive.com/pfg/PFG-DeckV1.pdf

About Intertainment – www.intertainmentmedia.com

Intertainment is one of Canada’s leading technology incubators and is focused on developing, nurturing and investing in both North American and global technologies and companies that provide technology solutions for brands and consumers alike. Intertainment also owns and operates a number of key properties and has investments in leading edge technologies and social media platforms, including TranzActive, CapThat, theAudience, Lexifone and Yappn Corp (www.yappn.com) (OTCQB:YPPN). For more information on Intertainment and its properties, please visit www.intertainmentmedia.com

Intertainment is headquartered in the Toronto, Canada region, with offices in New York and Los Angeles, CA and is listed on the TSX Venture Exchange under the symbol “INT” (TSXV: INT) and in the US under the symbol “ITMTF”. Intertainment is also traded in Europe on the Open Market (Regulate Unofficial Market) of the Frankfurt Exchange under the symbol “I4T”.

Contact

Mr. Anthony R. Pearlman, COO
info@intertainmentmedia.com

Forward Looking Information

This news release contains certain “forward-looking information” within the meaning of such statements under applicable securities law, including statements relating to the expected use of proceeds of the Offering.

Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Actual timelines associated may vary from those anticipated in this news release and such variations may be material. Actual results could differ materially because of factors discussed in the management discussion and analysis section of our interim and most recent annual financial statements or other reports and filings with the TSX Venture Exchange and applicable Canadian securities regulators. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on this forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Intertainment Media Inc.

ReleaseID: 429275

Dengue, Allergic Rhinitis And Brain Cancer Market Pipeline Review Up To 2015: Radiant Insights

RadiantInsights.com include new market research report “Dengue, Allergic Rhinitis And Brain Cancer Pipeline Market Review Up To 2015” to its huge collection of research reports.

Global Markets Direct’s, ‘Dengue – Pipeline Review, H1 2015’, provides an overview of the Dengue’s therapeutic pipeline.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

• The report provides a snapshot of the global therapeutic landscape of Dengue

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Dengue and enlists all their major and minor projects

• The report summarizes all the dormant and discontinued pipeline projects

For more Information About Dengue – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/dengue-pipeline-review-h1-2015

Allergic Rhinitis – Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Allergic Rhinitis – Pipeline Review, H1 2015’, provides an overview of the Allergic Rhinitis’s therapeutic pipeline.

Scope

• The report provides a snapshot of the global therapeutic landscape of Allergic Rhinitis

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Allergic Rhinitis and enlists all their major and minor projects

• The report summarizes all the dormant and discontinued pipeline projects

For more Information About Allergic Rhinitis – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/allergic-rhinitis-pipeline-review-h1-2015

Brain Cancer – Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Brain Cancer – Pipeline Review, H1 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

Scope

• The report provides a snapshot of the global therapeutic landscape of Brain Cancer

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Brain Cancer and enlists all their major and minor projects

For more Information About Brain Cancer – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/brain-cancer-pipeline-review-h1-2015

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/tie-ups and customized research solutions.

For more information, visit: http://www.radiantinsights.com/

Blog URL: http://www.terrapass.org/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/05/1432705703.png

“Radiant Insights”

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/dengue-pipeline-review-h1-2015

Source: ABNewswire

ReleaseID: 29046

Growth Investment Opportunity in Immersive Cinema Technology

WHITEFISH, MT / ACCESSWIRE / May 27, 2015 / With so many ways to consume movies at home, movie theaters are looking to attract business and maintain the bottom line by creating luxurious, immersive and customer-centric experiences at the cinema. In 2014 about 1.26 billion people went out to a movie, marking the lowest attendance figure since 1995. Yearly movie attendance can fluctuate wildly depending on the strength of that year’s blockbuster offerings, and the general outlook for 2015 is rosier. Still, the movie theater industry is looking for ways to put more people in the seats and increase profits.

IMAX Corporation (NYSE: IMAX) was an early innovator with large screens and advanced sound systems. Other chains have been developing offerings along similar lines lately. Regal Entertainment Group (NYSE: RGC), the largest chain in the United States, offers RPX(R) (Regal Premium Experience) theaters, featuring larger screens, state-of-the-art sound and projection systems as well as luxurious recliner seating. AMC Entertainment Holdings (NYSE: AMC), whose AMC Theatres comprise the U.S.’s second largest chain, similarly offer the “Dolby Theater at AMC Prime” theatres, utilizing Dolby Laboratories (NYSE: DLB) new Dolby Cinema(TM) system to add to the immersive experience. These are some of the bigger players in the industry, but investors looking for high growth opportunities might want to look at one of the smaller technology providers that is changing the way movies are presented.

The Guitammer Company Inc.

The Guitammer Company (OTC: GTMM) makes ButtKicker(R) brand low frequency audio transducers that transmit the feel of movies to the viewer by vibrating the seat in perfect synchronicity with the soundtrack. Explosions, rumbles and impacts come to life by adding the tactile sense (sense of touch) to the immersive cinema experience. These transducers are part of all of AMC’s Prime offerings (installed in all 10 theatres so far), and the company along with Regal recently announced the initial installation of ButtKicker units in Regal’s newest RPX theater. For a company with a very small market cap, cutting deals with the nation’s two largest chains could have a very large impact.

Additionally, Guitammer and RealD Inc. (NYSE: RLD) recently partnered with Warner Brothers (a segment of Time Warner Inc. (NYSE: TWX)) to outfit three high tech Cinetransformer mobile movie units. Basically, these are mobile movie theaters being driven around the U.S., Mexico and Europe promoting the upcoming earthquake blockbuster San Andreas. Step inside and people can view six minutes of the film in 4D, utilizing RealD 3D technology and feeling the earth move and quake as each and every seat is outfitted with a ButtKicker transducer.

Guitammer is in an interesting position that goes far beyond, but could be fed by, its growing cinema presence, as it has patented the technology to capture and broadcast, live and in real time, tactile-haptic data that allows the feel and impact of live sporting events to be delivered right to the consumer’s living room.

To that end, Guitammer and the San Jose Sharks partnered with Comcast SportsNet Bay Area to broadcast 2014-2015 Sharks home games in ‘4D’, delivering tactile data gathered from sensors in the boards of the arena directly to viewers at home. When the big hits happened on the ice, viewers at home could feel them on their couch. Fans and players alike reacted very positively. This pilot bears watching as Guitammer looks to capitalize on its plan to broadcast and to standardize this live tactile-haptic information in much the same way that Dolby has standardized the transmission of surround sound.

Guitammer’s revenue is trending upward, with the company’s Q1 2015 showing a 70% increase in revenues compared to Q1 2014. If the recent cinema deals are any indication, this trend could continue and make the company’s current ~$9M market pale in comparison to what it could be. Of course, if Guitammer’s plan to standardize the broadcast of tactile data – to ‘own the pipe’ and create a hardware-agnostic licensing stream of revenue – comes to fruition and meets broader market acceptance, early stage investors could be extremely grateful for having found this opportunity when they did.

Click here to receive future email updates on The Guitammer Company developments: http://www.tdmfinancial.com/emailassets/gtmm/gtmm_landing.php.

Disclaimer:

Except for the historical
information presented herein, matters discussed in this release contain
forward-looking statements that are subject to certain risks and
uncertainties that could cause actual results to differ materially from
any future results, performance or achievements expressed or implied by
such statements. Emerging Growth LLC is not registered with any
financial or securities regulatory authority, and does not provide nor
claims to provide investment advice or recommendations to readers of
this release. Emerging Growth LLC may from time to time have a position
in the securities mentioned herein and may increase or decrease such
positions without notice. For making specific investment decisions,
readers should seek their own advice. Emerging Growth LLC may be
compensated for its services in the form of cash-based compensation or
equity securities in the companies it writes about, or a combination of
the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx.

SOURCE: Emerging Growth LLC

ReleaseID: 429272

Scott Meadows Releases New Book Geared Towards Dental Marketing

May 27, 2015 – – Scott Meadows has recently announced the release of his new book entitled “Dental Marketing Secrets.” The book is geared towards helping dental practices that are looking to take advantage of online tools that can help them gain a foothold in the highly competitive world of search engine optimization and online marketing.

Meadows, who is already a best-selling author and local business advocate in Greenville, SC, uses his background in business marketing to outline little known secrets many of his previous clients have already used in order to find the success they were looking for. His strategies are based on his personal knowledge of the industry and the unique needs of businesses both large and small. He says,

“We know your needs as a business owner and know how to produce results. We understand the challenges every dentist faces every day while trying to run and grow their business.”

As the head of the Patient Prospectors team, he takes a completely different approach when it comes to marketing. His philosophy is based on a “People First” attitude where they take the time to determine the exact needs of their clients, their challenges, their goals, and their concerns. He feels that the more he learns about a particular business, the better their chances of guiding them to success.

In his book, he applies those same secrets to the dental industry, giving valuable advice on how to keep ahead of the competition in the world of online marketing. He says that those who do not know how to get potential clients calling them are “missing out on one of the most powerful marketing tools available.” With the secrets contained in his book, a dental business could grow their practice as much as seven times its current size within a span of just a few months.

In its pages, he outlines how to get started online if a dental practice hasn’t already made this step, how to get a website to work for itself, how to take care of their patients, and how to get their business to thrive.

Scott says there are several ways to implement a successful Dental SEO plan of action, many of which dental practices are getting wrong. He points out that other dental marketing companies may make great promises on the world of online marketing, but many of them never seem to follow through.

Reviewers of his book seem to agree. One reader comments:

“Scott is an expert marketer and in this book he outlines how Dental Practices can get more leads, calls & patients by implementing proven marketing methods.”

When a dental practice knows how to market its business in a way that will appeal to potential clients, their chances of increased leads may be unavoidable. Meadows brings these “secrets” out in the open so everyone who reads his book can take advantage of them.

The book is now available for purchase at Amazon.com for those who may be interested in learning his strategies for increasing online traffic to dental websites.

###

Contact Patient Prospectors:

Scott Meadows
877-925-8007
scott@patientprospectors.com
2320 E North St
Ste M
Greenville, SC 29607

ReleaseID: 60001255